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Abstract
Aquaporins (AQPs) are membrane channels that conduct water and small solutes such as glycerol and are involved in many
physiological functions. Aquaporin-based modulator drugs are predicted to be of broad potential utility in the treatment of
several diseases. Until today few AQP inhibitors have been described as suitable candidates for clinical development. Here
we report on the potent inhibition of AQP3 channels by gold(III) complexes screened on human red blood cells (hRBC) and
AQP3-transfected PC12 cells by a stopped-flow method. Among the various metal compounds tested, Auphen is the most
active on AQP3 (IC50 = 0.860.08 mM in hRBC). Interestingly, the compound poorly affects the water permeability of AQP1.
The mechanism of gold inhibition is related to the ability of Au(III) to interact with sulphydryls groups of proteins such as
the thiolates of cysteine residues. Additional DFT and modeling studies on possible gold compound/AQP adducts provide a
tentative description of the system at a molecular level. The mapping of the periplasmic surface of an homology model of
human AQP3 evidenced the thiol group of Cys40 as a likely candidate for binding to gold(III) complexes. Moreover, the
investigation of non-covalent binding of Au complexes by docking approaches revealed their preferential binding to AQP3
with respect to AQP1. The high selectivity and low concentration dependent inhibitory effect of Auphen (in the nanomolar
range) together with its high water solubility makes the compound a suitable drug lead for future in vivo studies. These
results may present novel metal-based scaffolds for AQP drug development.
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Introduction
AQPs belong to a highly conserved group of membrane
proteins called the major intrinsic proteins (MIPs) present in all
type of organisms and involved in the transport of water and small
solutes such as glycerol, nitrate and urea [1]. The 13 human AQP
isoforms (AQP0-12) are differentially expressed in many types of
cells and tissues in the body and can be divided into two major
groups: those strictly selective for water (called orthodox aqua-
porins) and those that besides water are also permeable to small
solutes including glycerol (called ‘‘aquaglyceroporins’’) [2]. Both
groups of channels are involved in many pathophysiological
conditions [3,4]. There is considerable potential for transferring
knowledge of AQP structure, function and physiology to the clinic,
and certainly there is great translational potential in aquaporin-
based therapeutics. AQP-based modulator drugs are predicted to
be of broad potential utility in the treatment of several diseases
such as kidney diseases, cancer, obesity, glaucoma, brain edema
and epilepsy [5]. In particular, recent studies have correlated
AQP3 glycerol permeation with skin tumorigenesis [6] and
identified it as being aberrantly expressed in melanoma [7],
suggesting that AQP3 might be a novel target for skin tumor
prevention and therapy.
There are at present very few reported AQP inhibitors that are
suitable candidates for clinical trials and none of them showed
specificity for AQP3 so far. Though various AQPs are inhibited by
mercurial compounds, such as HgCl2 [8], these substances are
non-selective in their action and extremely toxic. Other inorganic
salts such as AgNO3 and HAuCl4, that are prone to interact with
sulfhydryl groups of proteins as mercurials, have been also shown
to inhibit water permeability in plasma membrane from roots, and
in particular AgNO3 has been reported to efficiently inhibit water
permeability in human red blood cells (EC50 = 3.9 mM) [9].
Various other candidate blockers of AQP1 have been also
reported, including tetraethyl-ammonium [10], acetazolamide
[11] and DMSO [12]; however, other studies indicated little or
no AQP1 inhibition by tetraethylammonium salts or acetazola-
mide [13] and apparently inhibition by DMSO results from an
osmotic clamp effect rather than true inhibition [14]. Several
papers reported AQP4 inhibition by a series of arylsulfonamides,
antiepileptic drugs and related molecules, with strong inhibition at
low micromolar concentrations [15,16]; yet, these results could not
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be confirmed, with no inhibition activity found even at high
concentrations of any of the putative AQP4 inhibitors [17]. An
AQP4 inhibitor (2-nicotinamido-1,3,4-thiadiazole) was also shown
to reduce cerebral edema in rodent models [18], a radio-labeled
version of which has been developed to study AQP distribution in
vivo using PET [19]. Migliati et al. reported on AQP1 and AQP4
inhibition by an analogue of the sulfonamide Bumetamide [20],
that was also recently found to reduce cerebral edema in rodent
models [21] via AQP4 inhibition. Recently, Jelen et al. identified
novel small molecule inhibitors of AQP9 glycerol permeability;
however, since their solubility in aqueous solution is very limited,
these compounds are currently not suitable for in vivo experiments
[22].
Within this frame, we decided to reconsider metal-based
compounds as possible AQP inhibitors, and we report here the
inhibitory effect on the water and glycerol permeability mediated
by AQP1 and AQP3 of a series of metal complexes based on
different transition metals. The selected compounds are metal-
based drugs already known to possess different therapeutic
properties as anticancer, antirheumatic and antibacterial agents.
Among them were the anticancer drug cis-[PtCl2(NH3)2] (cisplatin)
[23], the antimetastatic trans-[Ru(dmso)(Him)Cl4] (dmso = di-
methylsulfoxide, Him = imidazole, NAMI-A) [24], the antibacte-
rial Ag(I) sulfadiazine (AgSDZ) [25], and the antirheumatic agent
aurothioglucose (AuTG) [26] (Figure 1). In addition, the gold(III)
compound [Au(phen)Cl2]Cl (phen = 1,10-phenatroline, Auphen)
[27,28,29] showing antiproliferative properties on cancer cells in
vitro, was also selected. For most of these compounds, the
mechanisms of pharmacological actions are still poorly understood
[30]. Therefore, AQPs also appeared to be interesting to
investigate as putative targets for metal-based drugs.
The effect of the compounds was tested by a stopped-flow
method on human red blood cells (hRBC) that specifically express
large amount of AQP1 and AQP3 [31,32], and confirmed on
transfected PC12 cell lines with overexpression of either AQP1 or
AQP3. In all cases, the gold(III) complex Auphen was the most
potent inhibitor and showed selectivity towards AQP3. Further
studies on a selected series of gold(III) complexes supported the
idea of the necessity of direct binding of gold ions to the protein to
achieve glycerol permeability inhibition. Additional DFT calcula-
tions on the interactions of gold(III) complexes with model amino
acids side chains, as well as docking studies investigating the non-
covalent binding of gold(III) complexes with both the known
structure of AQP1 and a homology model of AQP3, allowed to
provide a tentative description of the putative mechanisms of
inhibition and to explain the compounds’ selectivity for AQP3.
Results
Inhibition of water and glycerol permeability by metal
compounds
The effect of different metallo-drugs based on Pt(II), Ru(III),
Ag(I), Au(I,III) (Figure 1) was tested on water and glycerol
permeability of hRBCs. For this purpose hRBCs incubated in
isotonic phosphate buffered saline (PBS) solution were challenged
with hypertonic sucrose solution (impermeant solute, inducing cell
shrinkage) or hypertonic glycerol solution (permeant solute, cells
shrink due to the hyper-osmotic gradient and re-swell due to
glycerol entrance). Since hRBCs were shown to express large
amount of AQP1 and AQP3 accountable for membrane
permeability to water and glycerol [32,33,34], this assay allows
the direct evaluation of these aquaporins activity and is thus a
promising screening assay for modulators of aquaporin function.
From the rate of cell volume changes (shrinkage and re-swelling)
after imposed osmotic shocks, the membrane permeability for
water and for glycerol can be calculated [34].
Figure 2A shows the effect induced by the metal complexes
(0.1 mM concentration or higher) on AQP1 and AQP3 (10 min
incubation at room temperature) in comparison to HgCl2, a well-
known inhibitor of aquaporin activity, tested in the same
conditions. The obtained results demonstrated that the Au(III)
complex Auphen is the most effective of the series on glycerol
permeability, and far more effective than the mercurial compound
(with a statistical significance of P,0.001). For control hRBCs, the
osmotic water (Pf) and glycerol (Pgly) permeability values were
respectively (4.260.4)61022 cm s21 (n = 5) at 10uC and
Figure 1. Metal compounds used in this study.
doi:10.1371/journal.pone.0037435.g001
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(1.860.2)61025 cm s21 (n = 5) at 23uC. As shown in Figure 2A,
Auphen showed a modest effect on water permeability (ca. 20%
inhibition), while being able to drastically reduce glycerol transport
with a residual permeability of ca. 11% (90% inhibition). The
smaller effect obtained for water permeability points to a more
potent effect on AQP3, which itself is also a water-transporting
channel [35,36] but with a smaller contribution to the total bulk of
water flow through hRBC membranes where AQP1 is the main
water channel [32].
Representative traces of stopped-flow experiments with control
and hRBCs treated with even lower concentration of Auphen
(5 mM, incubated 30 min at room temperature) showing the
inhibition of the osmotic water flux or glycerol flux are reported in
Figure 2B and 2C, respectively.
To assure the compound selectivity, the effect of Auphen was
also tested on urea transport. Notably, no significant effect could
be observed for both concentrations tested in comparison to the
controls (P.0.05, n = 5) (Figure 2D). The ability of AQP3 to
transport urea has been debated [37,38]. In the erythrocyte, the
urea transporter UT-B [39] accounts for a very high urea
permeability reducing osmotic shrinkage of RBCs while passing
through the kidney. Therefore, compared to urea transporters,
urea permeability through AQP3 may have only a negligible
contribution and thus its inhibition would not be enough to
observe decreased urea permeability. Since Auphen did not affect
Figure 2. Effect of compounds on hRBC permeability. (A) Water and glycerol permeabilities (% of control) after treatment with the compounds
under study and with HgCl2 (10 min at r.t.) A marked effect of Auphen (100 mM) is depicted (***P,0.001). (B) Stopped flow representative traces of
water and (C) of glycerol permeability (control and after incubation with 5 mM Auphen, 30 min at r.t.). (D) Urea permeability showing no significant
effect of Auphen treatment (5 and 100 mM, 30 min at r.t.; P.0.05).
doi:10.1371/journal.pone.0037435.g002
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urea permeability, this result indicates that this metallodrug is
specific for AQP3 not having any effect on UT-B.
Following these promising results we further investigated the
inhibition of glycerol transport through AQP3 evaluating the effect
of the incubation time of hRBCs with Auphen. Figure 3A shows
the inhibitory effect of a fixed concentration of Auphen (5 mM)
where a maximum inhibition, after an exponential decay of
activity, could be observed after 30 min incubation of the samples
at r.t. It is worth mentioning that no cell hemolysis was detected
even after 4 hours incubation with the compound, pointing to a
non-toxic inhibitory effect. Subsequently, the concentration
dependent inhibition of glycerol transport in hRBC by Auphen
incubated 30 min at r.t. was assessed (Figure 3B). According to the
obtained results the IC50 value for Auphen was calculated as
0.860.08 mM.
The activation energy (Ea) for water and glycerol transport, a
valuable parameter indicating the contribution of protein channels
to permeation, was also estimated from an Arrhenius plot (Figure
S1). Upon treatment of hRBC with 5 mM Auphen, similar Ea
values for water transport were obtained for control
(3.960.4 kcal mol21) and Auphen treated hRBCs (4.161.0 kcal -
mol21). However, the Ea for glycerol permeation increased ca.
54% when Auphen was present (8.560.8 to 13.261.1 kcal -
mol21). Since the Auphen concentration used in the assay was
higher than the IC50 (corresponding approximately to 80%
inhibition), the increase in Ea is in accordance with a blockage
of the AQP3 channel. Regarding water transport, the observed
variation on the Ea was not significant (P.0.05); indeed, in hRBC
the contribution of the channel pathway to the total water
permeability is usually considered to be 90% while the bilayer adds
the remaining 10% [40]. The total 20% inhibition observed with
Auphen (Figure 2) would exclusively reduce the contribution of the
aquaporin (AQP1+AQP3) pathway maintaining the lipid pathway
intact, thus reflecting a decrease of the total permeability only to
ca. 87.5% of its initial value. Since the channel contribution for the
total permeability still remains very large, the Ea for water
transport is predicted not to be significantly affected.
Recovery of aquaporin activity by mercaptoethanol
In order to assess the reversibility of inhibition by Auphen,
hRBCs pre-treated with 2 mM Auphen for 30 min r.t. were
subsequently washed with PBS or with the reducing agent 2-
mercaptoethanol (EtSH, 1 mM in PBS). As seen in Figure 3C,
washing the sample twice with PBS had a limited effect in the
recovery of Auphen inhibition of glycerol permeability. Converse-
ly, incubation of the Auphen-treated hRBC sample with EtSH for
30 min produced an almost complete recovery of glycerol
permeability (ca. 90%), suggesting that EtSH effect on cysteine
residues is competing with Auphen binding to the pore [9].
The results obtained with EtSH, as well as the known affinity of
gold ions for binding to sulfhydryl groups of proteins, suggest that
AQP3 inhibition by Auphen might involve direct protein binding
of the Au centre to Cys residues as it has already been reported for
HgCl2. Indeed, mercury inhibition is likely to occur both via
covalent modification to Cys189 located immediately after the
extracellular entrance of the water pore of hAQP1 [41] and also to
other regions of the protein, causing either blockage or confor-
mational changes with a resultant inhibition of water transport
[42].
Selectivity of AQP3 inhibition in transfected cell lines
To further confirm the specific effect of Auphen on AQP3
glycerol transport, the inhibition of glycerol permeation by
Auphen was also assessed on PC12 cells stably transfected with
rat AQP1 or AQP3 (Table 1) [43]. Cell permeability for water and
glycerol was analyzed by stopped-flow experiments and results are
depicted in Figure 4A. The enhancement of water permeability for
AQP1 overexpressing cells (2.7 -folds) and that of glycerol
permeability for AQP3 overexpressing cells (1.8 -folds) correlates
well with their respective protein level of expression (Table 1).
When treated with Auphen (10 to 1000 mM, 30 min incubation at
r.t.) a decrease in glycerol permeability was only observed for the
PC12-AQP3 cell line, reaching 72% inhibition (Figure 4B); none
Figure 3. Effect of Auphen on hRBC glycerol permeability. (A)
Time dependent inhibition of glycerol permeability by 5 mM Auphen.
The inset shows the progressive decrease of glycerol permeability
observed in the assays where the increase in cell volume due to glycerol
entrance decreases drastically with the incubation time. (B) Concentra-
tion dependent inhibition of glycerol permeability in hRBC by Auphen
(compound concentrations in the range 0.1–10 mM; IC50 =
0.860.08 mM). (C) Inhibition of glycerol permeability (% of control) of
hRBCs after Auphen treatment (2 mM, 30 min at r.t.), and reversibility by
washing with PBS or incubation with 2-mercaptoethanol (1 mM for
30 min) (***P,0.001).
doi:10.1371/journal.pone.0037435.g003
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of the other two cell lines (wild type and PC12-AQP1) were
affected regarding glycerol. As for water permeability, only the
PC12-AQP1 showed an inhibition of ca. 25% for 100 mM
Auphen. It must be noted that higher concentrations of Auphen
were needed to produce the same inhibitory effect observed in
hRBCs. Besides the fact that Auphen might have a lower affinity
for rat AQP3 than for human AQP3, the possibility of Auphen
binding to other reactive groups within the whole cell membrane
decreasing its effective concentration in the media and therefore
leading to an underestimation of the IC50 should not be
disregarded. The PC12 cells are much larger than RBCs; hence,
the presence of a larger number of these bias reactive groups may
eventually contribute to a higher decrease in the effective Auphen
concentration available for AQP3 blockage.
Analysis of the mechanisms of AQP3 inhibition by
gold(III) compounds
In order to evaluate our mechanistic hypothesis that sees the
gold centre as responsible for AQP3 inhibition, the ligand Phen, as
well as the Au(III) complexes [Au(dien)Cl]Cl2 [28], (dien = diethy-
lentriamine, Audien) and [Au(cyclam)](ClO4)2Cl [28] (cy-
clam = 1,4,8,11-tetraazacyclotetradecane, Aucyclam) (Figure 5A)
were tested for glycerol transport inhibition in hRBCs. It must be
noted that Auphen and Audien, with AuN2Cl2 and AuN3Cl cores,
can undergo substitution of the chlorides with other nucleophiles
present in physiological environment. Instead, Aucyclam is a
gold(III) complex with a AuN4 chromophore which lacks of
chemical activation resulting into poor reactivity and scarce
biological (e.g. anticancer) effects [28]. The obtained results,
plotted in Figure 5B, confirm that while Audien at a concentration
of 50 mM reaches an inhibition of 80% (lower than the 90%
inhibition observed for Auphen at the same concentration), its
IC50 is 20-fold higher than observed for Auphen
(IC50 = 16.661.6 mM, Figure 5C). Notably, similarly to Auphen,
the inhibition of AQP3 by Audien reached its maximum at 30 min
incubation. On the other hand, Aucyclam and Phen are
completely inactive at any tested concentrations and incubation
times.
DFT calculations
The inhibition of AQP3 by Auphen and Audien is believed to
be related to the coordination of the Au(III) centre to a protein
residue in the pore, presumably cysteine, methionine or histidine
side-chains [44]. In order to establish the possibility of such a
mechanism and to elucidate possible structure-activity relation-
ships, DFT studies were performed to determine the molecular
geometry and the binding energy of these two selected Au(III)
compounds with several models of soft metal ion-binding protein
sites (Figure S2). A large body of knowledge on Au(III) chemistry
in water solutions [27] indicates that Auphen, and presumably also
Audien, is predominantly in its intact or hydroxo forms at neutral
pH, the diaquo form of Auphen being essentially negligible (Table
S1). Thus, both chloro and monohydroxo species, namely
[Au(phen)Cl2]
+ or [Au(phen)Cl(OH)]+, and [Au(dien)Cl]2+ or
[Au(dien)(OH)]2+), were taken into account for the DFT evalua-
tion of the Auphen and Audien binding at putative protein target
residues through the calculation of thermodynamics of the ligand
exchange process (Figure S3, Table S1) between Cl/OH and
suitable models of the side chains of Cys (L = CH3SH, CH3S
2),
Met (L = CH3SCH3), and His residues (L = CH3-Im), in different
polarity media.
The trend in Au–L binding strength estimated at this level of
theory (see Table S1) was CH3S.CH3Im.CH3SCH3.CH3SH
indicating the thiolate form of Cys as the most stable binding site
for Au(III) complexes, and the only one showing a favorable
reaction free energy with both Cl2 and OH2 ligands, together
with the CH3Im which, however, show a much smaller reaction
free energy. It must be noted that, while at physiological pH
cysteine residues are predominantly in their neutral form,
therefore appearing the least favorable target of Au(III) binding,
calculations on the acidic dissociation of thioalcohol complexes
gave negative free energy values and very low pKa’s (below zero),
indicating the facile deprotonation at neutral and even acidic pH
with formation of a metal-thiolate complex (Figure S3 and Figure
S4).
It is worth noting that the reaction free energy for Cl2
substitution by thiolate is much more favorable than for OH2,
thus suggesting that the ligand reactivity for Au(III) complexes is
different from that for cisplatin and other Pt(II) complexes where
the aqua-species are well known to be more reactive. This could be
due to the differences in redox properties of the Au(III)
compounds with respect to the Pt(II) complexes. Finally, the free
energy for Cl2 substitution by thiolate is slightly but significantly,
10–20 kJ mol21, more favorable for Auphen than for Audien,
suggesting a stronger binding of Aupen to Cys, in agreement with
its experimentally observed higher AQP3 inhibition.
Construction of the homology model of AQP3 and
comparison with AQP1 structure
Three homology models of human AQP3, namely hmod1,
hmod2 and hmod3, were obtained by the use of freely available
web-servers SWISS-MODEL, Phyre, and ESyPred, respectively,
based on the structurally characterized Escherichia coli glycerol
facilitator (GlpF) [45], the bacterial homolog of human AQP3, or
on its W48F, F200T mutant [46] as templates. The obtained
models (Dataset S1) were characterized by a high degree of
structure similarity, as evidenced by the overall good superimpo-
sition of helix domains and by the small values of RMSD of Ca
backbones. In addition, a moderate degree of structure similarity
was detected by the comparison of either side chain or loop
conformations, thus suggesting that the three homology models
may actually be characterized by similar binding properties. We
thus selected the hmod1 structure because it was characterized by
a slightly more favored ratio of model completeness: 250/292
residues for hmo1 with respect to 249/292 for both hmod2 and
hmod3.
The family of the aquaporins and the aquaglyceroporin
subfamily are known to share a common protein fold. It comprises
six membrane-spanning helices plus two half-helices with their
positive, N-terminal ends located at the centre of the protein and
their C-terminal ends pointing towards either side of the
membrane. The helices surround the 20-A˚-long and 3–4-A˚-wide
amphipathic AQP channel. AQPs are identified by two aspara-
gine-proline-alanine (NPA) sequence motifs located at the ends of
the two quasi 2-fold related half-spanning helices. The selectivity
filter, a constricted region formed by four residues near the
periplasmic/extracellular entrance, provides distinguishing fea-
tures that identify the subfamilies. In water selective AQPs this
region is smaller and more polar and contains a conserved
histidine residue, while in aquaglyceroporins it is larger and more
hydrophobic with two conserved aromatic residues [47]. Two
conserved constriction sites are present in the channel. An
aromatic/Arg (ar/R) constriction is located at the extracellular
pore mouth. Its diameter determines whether or not solutes, such
as glycerol and methylamine, can pass the AQP in addition to
water [48,49,50]. Furthermore, the positively charged residues in
this region form an energy barrier for protons. The second
constriction resides in the centre of the channel, where the positive
AQP3 Inhibition by Gold Compounds
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ends of the two half-helices meet. The helix dipole moments add
up to a full positive charge, and the resulting electrostatic field
poses another energy barrier for cations [51].
The structure of our homology model of AQP3 was analyzed in
detail and compared with the crystal structure of human AQP1 to
characterize the different propensity of both proteins for the
binding of the considered Au(III) complexes. Thus, the two AQP1
and AQP3 structures were analyzed by the SiteMap module of
Maestro for the identification and characterization of protein
binding pockets. Two major binding pockets were observed in
both AQP1 and AQP3, and, as expected, the mapping retraced
Figure 4. PC12 cell lines assays. (A) Permeability to water and glycerol of wild type PC12 cells and PC12 transfected with either AQP1 or AQP3.
Significant differences were found for the PC12-AQP3 clones (**P,0.01) for glycerol permeability, and for the PC12-AQP1 for water permeability
(***P,0.001) when compared to PC12-wt. (B) Effect of Auphen on glycerol permeability of PC12-AQP3 transfected cells (30 min incubation at r.t.).
doi:10.1371/journal.pone.0037435.g004
Table 1. Folds of expression and permeabilities of PC12 cells.
Clone Expression level PGly610
27 (cm s21) Pf610
22 (cm s21)
PC12wt 1.0 2.1660.64 3.7660.50
AQP1 4.0 1.9160.25 10.1161.84
AQP3 2.0 3.7860.24 4.0060.52
Folds of mRNA expression were determined by Northern blot analysis and are
normalized relative to the clone PC12wt.
doi:10.1371/journal.pone.0037435.t001
AQP3 Inhibition by Gold Compounds
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37435
the cavities corresponding to the water channels identifying a
binding pocket for each side of the protein, namely a periplasmic
and a cytoplasmic pocket separated by the selectivity filter (SF)
domain (Figure 6) [47].
The SiteMap comparison of periplasmic pockets of AQP1 and
AQP3 evidenced the main distinctive features of these protein
surfaces. In particular, an extended hydrophobic region was
detected in proximity of the SF of AQP3, but not in AQP1, the
latter showing a markedly higher hydrophilic character. This
result is in agreement with several literature evidences suggesting
the different hydrophilic/hydrophobic balance on the periplasmic
pocket as the major difference between orthodox aquaporin and
Figure 5. AQP3 inhibition by Au(III) compounds in hRBC. (A) Structures of the Au(III) complexes Audien and Aucyclam, and of the ligand phen.
(B) Effect of Auphen, phen, Aucyclam and Audien on glycerol permeability (% of control) after 30 min incubation at r.t. (***P,0.001). (C) Dose
response curve of Audien (IC50 = 16.6261.61 mM).
doi:10.1371/journal.pone.0037435.g005
Figure 6. Identification of protein binding pockets. Ribbon view of the whole protein channel (left) and periplasmic pocket (right) with
molecular surfaces displayed for AQP1 (top) and AQP3 (bottom). Hydrophilic and hydrophobic isosurfaces are also shown in light green and yellow,
respectively.
doi:10.1371/journal.pone.0037435.g006
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aquaglycerolporin subfamilies, including AQP1 and AQP3,
respectively [52].
Afterwards, the position and the chemical environment of the
most suitable soft-metal ion protein binding sites, such as cysteine,
methionine and histidine side chain residues, was analyzed in
detail. First of all, it must be noted that AQP3 is characterized by a
higher content of these residues (5 Cys, 5 Met and 6 His) in
comparison to AQP1 (4 Cys, 1 Met and 5 His). The mapping of
the periplasmic surface provided a valuable assessment of these
possible gold-binding sites location and exposure on both
aquaporin isoforms. In AQP1, Cys189 and His180 resulted to
be the only residues proximal to the periplasmic pore, therefore,
directly accessible to gold complexes. However, the exposure of
these residues is quite scarce and, being part of the SF domain,
they are located in the narrowest section of the membrane filter,
which can be easily approached only by small molecules.
Moreover, being the size filter function a conserved property of
SF [47], the transition to a ‘‘more open’’ conformation with
enhanced exposure of Cys189 and His180 is very unlikely.
On the other hand, AQP3 is characterized by the presence of a
MxxC motif located on the H1 domain, close enough to the
periplasmic pocket to be potentially targeted by metal complexes.
In this homology model, while Met37 is projected toward the
outer space of the protein (quite far from the pore surface and
probably in close contact with the membrane phospholipidic
layer), the thiol group of Cys40 is projected toward the periplasmic
space approaching the channel pore (Figure 7). The proximity of
Cys40 to the SF domain is further indicated by the partial burying
of this residue’s side chain by the guanidine moiety of Arg218.
Thus, among the possible gold binding sites available on AQP3,
the side chain of Cys40 is the most favorable, being very close to
the SF domain and in the right orientation.
Docking study of the non-covalent adducts of Au
complexes with AQP1 and AQP3
Although the Auphen and Audien inhibition is essentially
irreversible, a preliminary docking calculation has been carried out
to evaluate the accessibility of the proposed cysteine binding side
of AQP1 and AQP3, trying to identify non-covalent binding poses
and possible steric crashes. Thus, we considered the same species
assumed in the DFT calculations, i.e. Auphen and Audien and
their monohydroxo derivatives, and through the calculation of the
docking poses and their corresponding scoring we made a
preliminary estimation of both the affinity and accessibility of
these metal complexes to the targeted pores. In particular, the
molecular geometries of the Au(III) complexes obtained at DFT
level of theory were rigidly docked into the periplasmic pocket of
both AQP1 and AQP3 by using the Glide algorithm. The results
of docking studies are summarized in Table S2, and the most
representative calculated poses are depicted in Figure 8. In
general, docking calculations showed that the non-covalent
interaction of both Au(III) complexes is favored in the periplasmic
pocket of both AQP1 and AQP3. On the other hand, the
interaction of both Au(III) complexes with AQP3 is slightly
stronger as indicated by both the scoring of top ranked poses and
average score values (Table S2). Additionally, the analysis of the
docking poses indicated the AQP3 periplasmic pocket as the most
sterically accessible to the interaction of the considered Au(III)
complexes. Indeed, as shown in Figure 8, the top ranked poses of
both Au(III) complexes approached closer to the SF domain when
docked at AQP3, thus favoring the binding of these species at a
protein site closer to the constriction pore.
It is also worth noting that the Cys40 thiol group in AQP3 is in
proximity (9–10 A˚) and well-oriented with respect to the gold
centre of top ranked poses (Figure 8), thus confirming to be a
suitable metal binding site upon minimal adaptation of the protein
structure. On the other hand, the side chains of Cys189 and
His180, the only two possible metal sites at AQP1, are more
distant from the gold ion (12–14 A˚) and not favorably oriented to
be easily bound by Auphen and Audien.
Discussion
While AQP1 is a selective water channel, AQP3 permeates both
water and glycerol on human erythrocytes. In spite of being also a
water-transporting channel [35,36] its contribution to the total
Figure 7. Molecular surface of AQP3 periplasmic pocket. (A) SF
domain residues together with Cys40 side chain are displayed. (B)
Colour scheme representing the contributor atoms to the molecular
surface is also shown.
doi:10.1371/journal.pone.0037435.g007
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bulk of water flow through hRBC membranes is minimal
compared to AQP1 [32]. Conversely, AQP3 has been shown to
mediate most of the glycerol movements across RBCs membranes
[32,34]. In addition to its expression in hRBCs, AQP3 has a wide
tissue distribution in the epithelial cells of kidney, airways and skin,
suggesting a role in water reabsorption, mucosal secretions, skin
hydration and cell volume regulation [53]. Moreover, a recent
study reported an aberrant AQP3 expression in melanoma and
proved that it significantly increases chemoresistance to arsenite
treatment [7].
In the present study we report on the screening of different
known metallodrugs, with various therapeutic applications, for the
inhibition of AQP1 and AQP3. Thus, the potent and selective
inhibition of the glycerol permeability through AQP3 in hRBC by
water soluble gold(III) complexes, namely Auphen and Audien,
was observed, while the other metal complexes were completely
ineffective as AQPs inhibitors. Both the effective compounds are
tetracoordinated gold(III) complexes with square planar geometry
in which the Au(III) oxidation state, at variance with the case of
NaAuCl4, is stabilized by the presence of nitrogens on the
phenantroline and diethylentriamine ligands. Auphen and Audien
resulted to inhibit glycerol transport in hRBC with an
IC50 = 0.860.08 mM and IC50 = 16.661.6 mM, respectively, while
having only a modest inhibitory effect on water permeability.
Moreover, the gold(III) compounds also resulted to be ineffective
as inhibitor of urea transport on hRBC.
The observed increase in the Ea for glycerol transport in hRBC
with no concomitant Ea change for water transport upon
treatment with Auphen, points to a potent blockage of the
AQP3 channel with a much lower effect on AQP1. A similar effect
has already been reported in the case of Cu2+ and Ni2+ ions, which
were shown to inhibit selectively AQP3 in transfected human cell
lines, although at higher concentrations in the mM range [54,55].
Notably, the Au(III) compounds are also much more effective on
AQP3 than the non-specific inhibitor of aquaporins HgCl2, and
most importantly they are not toxic for the cells in the entire range
of investigated concentrations as suggested by the absence of
hemolysis and by the recovery of activity after treatment with
EtSH.
The specificity of Auphen towards AQP3 was further confirmed
by assessing glycerol transport on PC12 cell lines transfected with
either AQP1 or AQP3 from rat. The marked inhibitory effect of
the compound for the PC12-AQP3 cell clone denotes its higher
affinity for AQP3 residues.
The time-dependent inhibition of AQP3 by Auphen is in
accordance with the typical reactivity pattern of this gold(III)
Figure 8. Docking of Auphen and Audien on AQP1 and AQP3. Top ranked poses of Auphen (top) and Audien (bottom) at periplasmic pocket
of AQP1 (left) and AQP3 (right). Positions of metal centre for the other calculated poses are also displayed in golden yellow. SF domain residues are
labelled in blue. Au–S and Au–N distances are reported in A˚.
doi:10.1371/journal.pone.0037435.g008
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complex in aqueous solution. It is worth mentioning that, as
commonly found for several other metallodrugs, gold(III) com-
pounds behave as ‘‘prodrugs’’ [56]. In other words, their adducts
with biomolecular targets are often the result of a specific chemical
transformation (e.g. ligand substitution, redox processes, hydroly-
sis) of the compounds. In the case of Auphen, AQP3 binding is
most likely achieved through substitution of at least one halide
ligand from the tetracoordinated gold(III) chromophore AuN2Cl2
[28]. Similarly, Audien can bind AQP3 after replacement of the
unique chloride ligand, but slightly less efficiently than Auphen as
demonstrated by its higher IC50 value. Conversely, the chemically
stable Au(III) complex Aucyclam shows lack of inhibition
properties supporting the hypothesis that the gold centre is
essential for inhibition and most likely is involved in protein
binding.
The mechanism of gold inhibition is probably due to the ability
of Au(III) to interact with sulphydryl groups of proteins such as the
thiolate of cysteine. This hypothesis is partly confirmed by the
almost complete recovery of AQP3 activity upon treatment of
hRBC with EtSH. However, other modes of Auphen binding
might also occur (e.g. with histidine groups). In order to shed light
on the putative binding modes of gold complexes to AQPs we used
DFT analysis. Thus, DFT calculations on the reactions of Auphen
and Audien with model side chain residues indicated the thiolate
form of Cys as the most favorable binding site for Au(III)
complexes both in the intact or mono-hydroxo species.
To further investigate the mechanisms of AQP inhibition by
gold compounds at a molecular level, we undertook molecular
modeling studies. Initially, a homology model of human AQP3
was built and compared to the structure of human AQP1 via
molecular modeling SiteMap analysis, allowing the identification
and characterization of protein binding pockets. Our model
confirmed the well-established presence of an extended hydro-
phobic area in the periplasmic region of AQP3, while a marked
hydrophilic character was evidenced in the same region of AQP1.
This important difference might account for a higher binding
affinity of the Auphen complex for AQP3 with respect to Audien,
resulting in higher inhibition potency, being the phenantroline
ligand likely to establish hydrophobic interactions at the entrance
of the glyceroporin channel. Most importantly, the mapping of the
periplasmic surface allowed establishing the possible gold binding
sites and their exposure on both aquaporin isoforms. In AQP1
none of the cysteine, methionine or histidine residues appear to be
accessible for gold binding, including Cys189 previously reported
to be the binding site of mercurial AQP inhibitors [42].
Conversely, in AQP3 the thiol group of Cys40 is projected
towards the periplasmic space approaching the channel pore and,
therefore, it is proposed here as a likely candidate for binding to
gold(III) complexes.
The investigation of non-covalent binding of Auphen and
Audien and their monohydroxo species at AQP1 and AQP3 by
docking approaches allowed to ascertain the possibility for the gold
complexes to reach the SF domain of AQP3 in closer proximity
with respect to AQP1, therefore allowing the compounds to bind
at protein sites closer to the constriction pore of the aquaglycer-
oporin such as the side chain of Cys40. Indeed, it is known that the
AQP1 channel cross-section size is the major determinant of
selectivity for larger amphipathic molecules such as glycerol [47].
Thus, the same steric restrictions which account for the poor
glycerol permeation by pure water channels with respect to
aquaglyceroporins, might also apply to gold(III) complexes. In
addition, the analysis of docking scores evidenced a slightly higher
affinity of the two compounds for the AQP3 periplasmatic pore,
characterized by a higher extent of hydrophobic sites with respect
to AQP1. The highest docking scores for the approach of Auphen
at the targeted periplasmic pore, together with the strongest
binding of Auphen to Cys shown by our DFT calculations, can
explain the slightly higher inhibitory potency demonstrated by
Auphen.
Interestingly, both Auphen and Audien have been previously
reported to possess anticancer properties in vitro [28,29]. Indeed, in
recent years several gold(III) compounds have shown promising
anticancer effects related to the inhibition of different protein
targets, such as the proteasome and specific zinc finger proteins
[57,58,59,60]. In this context, we cannot exclude that inhibition of
AQP3 might influence the biological effects of the compounds
towards cancer cells, although other studies need to be performed
to validate such a hypothesis.
In conclusion, metal compounds, in particular mercurial salts,
have already been reported as inhibitors of AQPs, but have major
drawbacks such as poor selectivity and extreme toxicity, which
hamper their development as therapeutic agents. We described
here the selective and potent inhibitory effect (in the nanomolar
range) of two Au(III) complexes bearing nitrogen donor ligands on
AQP3, which together with their limited toxicity and high water
solubility makes them suitable candidates for future in vivo studies.
These results may present novel metal-based scaffolds for AQP
drug development.
Methods
Chemistry
Gold compounds and NAMI-A were prepared according to
literature procedures (see references throughout the text). The
purity of the compounds was confirmed by elemental analysis, and
all of them showed purity greater than 98%. Cisplatin, silver
sulfadiazine, aurothioglucose and 2-Mercaptoethanol were from
Sigma.
Ethics Statement
Venous blood samples were obtained from healthy human
volunteers following a protocol approved by the Ethics Committee
of the Faculty of Pharmacy of the University of Lisbon. Informed
written consent was obtained from all participants. Rat adrenal
medulla pheochromocytoma cells (PC12) were kindly provided by
Dr. M. Eschevarria, Virgen del Rocio University Hospital, Seville
[33].
Erythrocyte sampling and preparation
Venous blood samples, collected in citrate anticoagulant (2.7%
citric acid, 4.5% trisodium citrate and 2% glucose). Fresh blood
was centrifuged at 7506g for 5 min at 4uC and plasma and buffy
coat were discarded. Packed erythrocytes were washed three times
in PBS (KCl 2.7 mM, KH2PO4 1.76 mM, Na2HPO4 10.1 mM,
NaCl 137 mM, pH 7.4), diluted to 0.5% haematocrit and
immediately used for experiments [34].
Cell Culture and Transfections
To obtain stable clones of PC12 (cell line derived from a
pheochromocytoma of rat adrenal medulla) that overexpress either
rat AQP1 or rat AQP3, twenty micrograms of pcDNA3-AQP1 or
pcDNA3-AQP3 were transfected into wild type PC12 by
electroporation. After selection with geneticin sulphate (GIBCO)
40 clones were analyzed for levels of expression of either AQP1 or
AQP3. Out of 20 positive clones with variable levels of AQPs
expression, for each AQP those with higher expression were
selected. PC12 cells were cultured in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 5% foetal bovine serum,
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10% horse serum, and 1% penicillin/streptomycin (Invitrogen) in
a CO2 (10%) incubator at 37uC. Geneticin at 0.2 mg/ml was
added to culture AQP-overexpressing clones. Levels of AQP
overexpression were determined by Northern blot analysis and
expressed relative to wild type PC12. RNA analysis and functional
characterization of these clones have been described in detail
previously [43].
Cell volume measurements
hRBC mean volume in isotonic solution was determined using a
CASY-1 Cell Counter (Scha¨rfe System GmbH, Reutlingen,
Germany) and was calculated as 82 fL. Equilibrium volumes of
PC12 cells were obtained by phase contrast microscopy on an
inverted microscope (Axiovert Zeiss 100M) equipped with a digital
camera.
Plated cells were dislodged by mechanical aspiration with
pipette, washed and re-suspended in PBS. For each measured set
of data, an aliquot of cell suspension was placed on a microscope
slide and an average of 6 pictures with 4–6 cells each were taken
and analyzed using NIH ImageJ software. Cells were assumed to
have a spherical shape with a diameter calculated as the average of
the maximum and minimum dimensions of each cell. Calculated
volumes were 10766123 mm3 for all the clones measured.
Stopped-flow light scattering experiments
Stopped-flow experiments were performed on a HI-TECH
Scientific PQ/SF-53 apparatus, with 2 ms dead time, temperature
controlled and interfaced with a microcomputer. Experiments
were performed at 23uC for glycerol permeability and at 10uC for
water and urea permeability; for activation energy measurements
temperatures were ranged from 10uC to 37uC. For each
experimental condition, 5–7 replicates were analyzed. For
measuring the osmotic water permeability (Pf), 100 mL of a
suspension of fresh erythrocytes (0.5%) or PC12 cells (1.56103 to
3.56103 cells/mm3) was mixed with an equal volume of PBS
containing 200 mM sucrose as a non-permeable osmolyte to
produce a 100 mM inwardly directed sucrose gradient [34]. The
kinetics of cell shrinkage was measured from the time course of 90u
scattered light intensity at 400 nm until a stable light scatter signal
was attained.
Pf was estimated by Pf = k (Vo/A)(1/Vw(osmout)‘), where Vw is the
molar volume of water, Vo/A is the initial cell volume to area ratio
and (osmout)‘ is the final medium osmolarity after the applied
osmotic gradient and k is the single exponential time constant
fitted to the light scattering signal of erythrocyte shrinkage. For
PC12 cells, a double exponential function was used instead and the
weighted averaged rate constant kde = (DI1k1+DI2k2)/(DI1+DI2),
where DI1 and DI2 correspond to the signal changes with either a
slow rate constant k1 or a fast one k2, was alternatively used to
calculate Pf [61].
For glycerol permeability (Pgly), 100 mL of erythrocyte or PC12
cell suspension was mixed with an equal volume of hyperosmotic
PBS containing 200 mM glycerol creating a 100 mM inwardly
directed glycerol gradient. After the first fast cell shrinkage due to
water outflow, glycerol influx in response to its chemical gradient
was followed by water influx with subsequent cell reswelling. Pgly
was calculated as Pgly = k (Vo/A), where k is the single exponential
time constant fitted to the light scattering signal of glycerol influx
in erythrocytes [34]. The same protocol was performed for urea
permeability, but using instead a hyperosmotic PBS solution
containing 200 mM urea. For PC12 cells, the rate of re-swelling
due to glycerol influx was measured as the slope of a linear
regression fit.
For inhibition experiments cells were incubated with different
concentrations of complexes, from freshly prepared stock aqueous
solutions, for various times at room temperature before stopped-
flow experiments. A time dependent inhibition assay for Auphen
over several hours incubation with hRBC and PC12 cells showed
no further increase of inhibition after 30 min at r.t. A similar time
dependent inhibition assay was performed for all the compounds
up to 4 hours incubation at r.t. except for the highly toxic HgCl2
(10 min, r.t.). The inhibitor concentration necessary to achieve
50% inhibition (IC50) was calculated by nonlinear regression of
dose-response curves (Graph Pad Prism, Inc) to the equation:
y = ymin+(ymax2ymin)/(1+10((LogIC50-[Inh]) H)), where y is the per-
centage inhibition obtained for each concentration of inhibitor
[Inh] and H is the Hill slope. The activation energy (Ea) of water
and glycerol transport was calculated from the slope of the
Arrhenius plot (lnPf or lnPgly as a function of 1/T) multiplied by the
gas constant R. All solution osmolarities were determined from
freezing point depression on a semi-micro osmometer (Knauer
GmbH, Berlin, Germany) using standards of 100 and 400 mOsM.
Statistic analysis
Data were presented as mean 6 standard error of the mean
(SEM) of at least four independent experiments, and were
analyzed with either the paired Student’s t-test or one-way
analysis of variance (ANOVA) followed by Tukey’s test. A value of
P#0.01 was considered to be statistically significant.
QM calculations
The structures of Au(III) complexes, i.e. Auphen and Audien,
and their respective hydrolyzed forms were investigated at DFT
level of theory with the B3LYP hybrid functional [62,63], which is
known to give good descriptions of transition metal-containing
compounds [64,65]. The core electrons of the chloride and metal
atoms were described with the Hay and Wadt core-valence
relativistic effective core-potential (ECP) leaving the outer
electrons to be treated explicitly through the basis set denoted as
LACV3P* in Jaguar [66], while for the remaining atoms the 6-
311G** basis set was used [67]. Each structure was optimized in
the gas phase (e= 0) and frequency calculations were performed to
verify the correct nature of the stationary points and to estimate
zero point energy (ZPE) and vibrational entropy corrections at
room temperature. Single point energies of all stationary points
were calculated by using the larger 6-311++G** set for the main
group elements, and the LACV3P++** set for the metal and the
chloride atoms. The Poisson-Boltzmann (PB) continuum solvent
method was employed to simulate e.0 environments, namely a
low-polarity medium resembling the inner protein with e= 4 and
an aqueous medium with e= 80 [68].
The thermodynamics of Auphen and Audien aquation (I) and
acidity of the corresponding aquo (II) and methanethiol (III)
complexes was investigated by means of the thermodynamic cycles
depicted in Figure S2. The reaction free energy for the exchange
processes involving metallodrug species was first calculated at DFT
level of theory while the free energy values for the processes of
interest, i.e. DGuI, DGuII and DGuIII, were obtained as reported in
Figure S2. The DGu values obtained by this indirect procedure are
expectedly subjected to less approximations than those calculated
for the respective direct processes because the inclusion of
empirical parameters such as the solvation energy of proton and
chloride ion, characterized by large and negative values (and thus
affected by larger approximation), is avoided. The corresponding
values of pKa for the acidic dissociation reaction II and III were
calculated by the equation pKa =DGurea/2.303 RT, where R is the
ideal gas constant and T is 298.15 K.
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The Jaguar 7.7 quantum chemistry package was used for all
calculations [69].
Molecular modeling
The crystal structure of AQP1 was downloaded from the PDB
archive (entry code 1H6I) [70] and processed in the Maestro
environment [71]. Thus, the pdb structure of AQP1 underwent
the Protein Preparation workflow to remove water and other co-
crystallized molecules, to assign the most plausible formal charge
to the ionisable protein residues and to eventually add hydrogen
atoms. After these steps, the protein structure was relaxed in a
OPLS2001 [72,73] force field through a conjugate-gradient
minimization algorithm and a gradient-based convergence
threshold of 0.3 kJ mol21 A˚21, allowing to preserve the main
features of the parent crystal conformation in the final structure of
AQP1.
The 3D structure of AQP3, not yet resolved, was obtained by
homology modeling on accessible web-servers as follow. Initially,
possible AQP3 homologues were searched using the HHmod web-
server [74,75]. Among the top ranked homologues 1LDA and
1LDF [46] were selected as templates for subsequent homology
modeling on the above cited web-servers. However, the homology
models obtained by 1LDF as template were either incomplete or
presenting structural misfolding, so that only the three models
generated by 1LDA were considered afterwards, namely hmod1,
hmod2 and hmod3 from Swiss-Model, Phyre, and ESyPred,
respectively.
The three homology models were subjected to a Protein
Preparation procedure by the same treatment employed for AQP1
(see above). After this step, the structures of AQP1 and hmod1-3
were superimposed in the Maestro workspace by using the protein
alignment tool and then processed by the SiteMap module [76].
This tool adopts a grid-based procedure to map the space
surrounding the protein structure by employing volumetric,
electrostatic and hydrophobic probes. By the identification and
characterization of protein cavities, SiteMap is able to retrace the
possible binding pockets from a protein structure. The molecular
surface, the hydrophobic and hydrophilic isosurfaces of each
identified site are measured and used to calculate the correspond-
ing site score.
The SiteMap calculation on AQP1 was performed by essentially
using the default parameters with the exception of the mapping
resolution set to 0.3 to gain the maximum mapping accuracy.
Docking calculations were carried out with Glide 3.5 that makes
use of a series of hierarchical filters to calculate the ligand binding
poses in the active-site region of the target [77]. The periplasmic
pore of AQP1 and AQP3 was selected as docking active region
through a 30630630 grid centered on to the center of mass of SF
domain residues for each protein structure, namely residues 56,
180 189 and 195 for AQP1 and residues 63, 203 212 and 218 for
AQP3. The positional space of Au(III) complexes was instead
limited to a 15615615 box centered as already mentioned; these
settings are default for grid calculation with Glide3.5 [77].
Docking was performed using the standard parameters set-up for
rigid docking in which only the roto-translational degrees of
freedom were explored and metal complexes kept the correspond-
ing DFT geometry. The evaluation of binding pose quality was
performed in terms of GlideScore as function of ligand-target
molecular mechanics interaction energy and ligand strain energy.
A maximum of 30 docking poses per metal complex were searched
in each docking run.
Supporting Information
Figure S1 Arrhenius plots showing the water and glycerol
permeability of hRBS, in the absence (control) or presence of
5 mM Auphen (30 min incubation at r.t. previous to permeability
measurements). Activation energy (Ea) values for water transport
were not affected by Auphen treatment (3.960.4 kcal mol21 for
control and 4.161.0 kcal mol21 for Auphen treated hRBCs). The
Ea for glycerol permeation increased ca. 54% when Auphen was
present (8.560.8 to 13.261.1 kcal mol21).
(TIF)
Figure S2 Reaction of Au(III) complexes with soft-metal protein
sites investigated at DFT level of theory.
(TIF)
Figure S3 Two-step formation of the Au–thiolate adduct
between Auphen and Cys side chain.
(TIF)
Figure S4 Calculation of reaction free energies in water for the
I) aquation of Audien (X = NH2) and Auphen (X = Cl), II) acidic
dissociation of their respective aquo forms and III) acidic
dissociation of corresponding thiol adducts, and the corresponding
pKa values of the two latter processes. All free energy values were
reported in kJ mol21. Values of Khyd
Pt and Ka1
Pt, referred to the
cisplatin first hydrolysis and to the acidity of the corresponding
monaquo form, respectively, were taken from B. Lippert,
‘‘Cisplatin’’ 1999, Wiley-VCH, Weinheim, Germany, pp 184,
186.
(TIF)
Table S1 Calculated enthalpies and free energies for the
reaction of Auphen and Audien with soft-metal protein sites in
different polarity media. All values are in kJ mol21.
(DOC)
Table S2 Docking score of Auphen and Audien at periplasmic
pocket of AQP1 and AQP3.
(DOC)
Dataset S1 Calculated homology modelling structures (pdb
format) of AQP3. Available at http://www.ff.ul.pt/fct/dataset_s1.
pdf.
(PDF)
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